CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Hallmarks of Cancer: Inducing Angiogenesis Energetics

Read More
All Posts

Cancer cells stimulate the growth of blood vessels to supply nutrients to tumors. Angiogenesis is the formation of new blood vessels from pre-existing blood vessels. This plays an important role in tumor growth.

18-CEL-47663-Blog-Hallmarks-Cancer-3-Inducing-Angiogenesis

Benign tumors can exist in a dormant state, which can be driven by inadequate access to sufficient blood supply. However, the "angiogenic switch" occurs when angiogenesis is activated in a dormant tumor and growth factors are secreted to induce sprouting and chemotaxis of endothelial cells toward the tumor mass.

Within the hypoxic environment of the tumor mass, hypoxia inducible factor-1 (HIF-1) is stabilized and activates the expression of multiple genes contributing to the angiogenic process, including vascular endothelial growth factor (VEGF) and fibroblast growth factor (bFGF), or platelet-derived growth factor (PDGF).

Click the angiogenesis pathway link to learn more about the related proteins implicated in this Hallmark of Cancer:

 - Angiogenesis Pathways

Check out the complete guide to the Hallmarks of Cancer Research targets. Download the eBook Now.

The Hallmarks of Cancer were identified by Doctors Robert Weinberg and Douglas Hanahan and were originally published in Cell1. The authors propose the idea that the complexity of cancer can be broken down into smaller subsets of underlying principles. The information here pertains to one such subset. Other entries in this series explore the other known Hallmarks.

Read the additional blog posts in the Hallmarks of Cancer series to learn more:

  1.  Hanahan D, Weinberg RA (January 2000). "The Hallmarks of Cancer". Cell. 100 (1): 57–70. doi:10.1016/S0092-8674(00)81683-9
  2. Hanahan D, Weinberg RA (March 2011). "Hallmarks of Cancer: the next generation". Cell. 144 (5):646-74. doi: 10.1016/j.cell.2011.02.013.
Chris Sumner
Chris Sumner
Chris Sumner was the Editor-in-Chief of Lab Expectations. When he's not reading/writing about curing disease, he's hiking in the woods, playing guitar, or searching for the world's best lobster roll.

Recent Posts

Do You Trust Your Research Antibody?

There’s no getting around it: Selecting the right antibody can make or break your experiment. If the reag...
Alexandra Foley Feb 26, 2025

Why is combining single cell RNA and intracellular signaling data difficult?

What if you could measure RNA, determine cell type, and detect intracellular signaling, all in a single c...
Alexandra Foley Feb 19, 2025

Does It Really Work? How InTraSeq™ Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

The ability to detect intracellular proteins alongside RNA has long been a challenge in single cell resea...
Alexandra Foley Feb 12, 2025